FR2392023A1 - Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant - Google Patents

Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant

Info

Publication number
FR2392023A1
FR2392023A1 FR7815029A FR7815029A FR2392023A1 FR 2392023 A1 FR2392023 A1 FR 2392023A1 FR 7815029 A FR7815029 A FR 7815029A FR 7815029 A FR7815029 A FR 7815029A FR 2392023 A1 FR2392023 A1 FR 2392023A1
Authority
FR
France
Prior art keywords
indoles
pyrido
hexahydro
aryl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7815029A
Other languages
English (en)
French (fr)
Other versions
FR2392023B1 (it
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2392023A1 publication Critical patent/FR2392023A1/fr
Application granted granted Critical
Publication of FR2392023B1 publication Critical patent/FR2392023B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7815029A 1977-05-23 1978-05-22 Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant Granted FR2392023A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79939277A 1977-05-23 1977-05-23

Publications (2)

Publication Number Publication Date
FR2392023A1 true FR2392023A1 (fr) 1978-12-22
FR2392023B1 FR2392023B1 (it) 1980-11-07

Family

ID=25175793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7815029A Granted FR2392023A1 (fr) 1977-05-23 1978-05-22 Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant

Country Status (31)

Country Link
JP (1) JPS53144600A (it)
AR (2) AR217688A1 (it)
AT (1) AT368995B (it)
AU (1) AU499618B1 (it)
BE (1) BE867249A (it)
CA (1) CA1094071A (it)
CH (1) CH634321A5 (it)
CS (1) CS207612B2 (it)
DD (4) DD146186A5 (it)
DE (1) DE2822465C2 (it)
DK (1) DK226678A (it)
EG (1) EG13590A (it)
FI (1) FI63402C (it)
FR (1) FR2392023A1 (it)
GB (1) GB1586655A (it)
GR (1) GR69985B (it)
HU (3) HU187782B (it)
IE (1) IE46975B1 (it)
IL (1) IL54755A (it)
IT (1) IT1096307B (it)
LU (1) LU79684A1 (it)
NL (1) NL7804210A (it)
NO (2) NO150204C (it)
NZ (1) NZ187333A (it)
PH (1) PH13756A (it)
PL (5) PL114541B1 (it)
PT (1) PT68058B (it)
SE (2) SE441448B (it)
SU (4) SU873883A3 (it)
YU (4) YU91478A (it)
ZA (1) ZA782918B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2447379A1 (fr) * 1979-01-23 1980-08-22 Pfizer Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253520A1 (it) * 1973-12-06 1975-07-04 Lab Inc
FR2264535A1 (it) * 1974-03-20 1975-10-17 Dainippon Pharmaceutical Co

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253520A1 (it) * 1973-12-06 1975-07-04 Lab Inc
FR2264535A1 (it) * 1974-03-20 1975-10-17 Dainippon Pharmaceutical Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2447379A1 (fr) * 1979-01-23 1980-08-22 Pfizer Trans-5-aryl-2,3,4,4a-5-9b-hexahydro-1h-pyrido (4,3-b) -indoles substitues en position 2 dextrogyres, procedes et composes intermediaires permettant de les obtenir et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
PL116944B1 (en) 1981-07-31
DK226678A (da) 1978-11-24
PL117107B1 (en) 1981-07-31
PH13756A (en) 1980-09-17
NL7804210A (nl) 1978-11-27
YU221782A (en) 1983-01-21
NO150204C (no) 1984-09-05
DD145536A5 (de) 1980-12-17
PL206903A1 (pl) 1979-10-22
SE7803625L (sv) 1978-11-24
PL114547B1 (en) 1981-02-28
AR221721A1 (es) 1981-03-13
PT68058B (en) 1979-10-24
DE2822465A1 (de) 1978-11-30
SE441448B (sv) 1985-10-07
DD145537A5 (de) 1980-12-17
IE781013L (en) 1978-11-23
DD138321A5 (de) 1979-10-24
NZ187333A (en) 1984-05-31
GB1586655A (en) 1981-03-25
SE8305917D0 (sv) 1983-10-27
SE8305917L (sv) 1983-10-27
PL114541B1 (en) 1981-02-28
SU843749A3 (ru) 1981-06-30
FI63402B (fi) 1983-02-28
IT7823673A0 (it) 1978-05-22
JPS5711912B2 (it) 1982-03-08
ZA782918B (en) 1979-06-27
SU841589A3 (ru) 1981-06-23
YU221882A (en) 1983-01-21
HU188802B (en) 1986-05-28
YU40796B (en) 1986-06-30
IE46975B1 (en) 1983-11-16
SU818484A3 (ru) 1981-03-30
CH634321A5 (en) 1983-01-31
IL54755A (en) 1981-02-27
JPS53144600A (en) 1978-12-15
LU79684A1 (fr) 1979-12-06
CS207612B2 (en) 1981-08-31
SU873883A3 (ru) 1981-10-15
NO831790L (no) 1978-11-24
AT368995B (de) 1982-11-25
CA1094071A (en) 1981-01-20
NO781770L (no) 1978-11-24
EG13590A (en) 1982-03-31
IL54755A0 (en) 1978-07-31
YU91478A (en) 1983-01-21
FR2392023B1 (it) 1980-11-07
YU221682A (en) 1983-01-21
DD146186A5 (de) 1981-01-28
ATA369678A (de) 1982-04-15
FI781612A (fi) 1978-11-24
HU185009B (en) 1984-11-28
NO150204B (no) 1984-05-28
SE448459B (sv) 1987-02-23
HU187782B (en) 1986-02-28
AR217688A1 (es) 1980-04-15
BE867249A (fr) 1978-11-20
PT68058A (en) 1978-06-01
NO151862B (no) 1985-03-11
GR69985B (it) 1982-07-22
FI63402C (fi) 1983-06-10
AU499618B1 (en) 1979-04-26
IT1096307B (it) 1985-08-26
NO151862C (no) 1985-06-19
DE2822465C2 (de) 1986-08-28

Similar Documents

Publication Publication Date Title
MA26733A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
EA199800531A1 (ru) Водные суспензии сложных эфиров жирной кислоты 9-гидроксирисперидона
FI954130A0 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI935847A (fi) L-DOPA-esterikoostumukset
FR2404625A1 (fr) Nouveaux 4-aminocyclohexanols et composition pharmaceutique les contenant
FR2362834A1 (fr) Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant
IE50549B1 (en) Pharmaceutical compositions containing a corticosteroid substance
FR2392023A1 (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
FR2355029A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside, son procede de preparation et medicament le contenant
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
FR2385691A1 (fr) Nouveaux derives d'acides diarylmethyleneaminooxyalcanoiques, leur procede de preparation et medicament les contenant
FR2375222A1 (fr) Nouveaux composes du type (2-benzothiazolyl)oxamate, leur procede de preparation et medicament les contenant
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2404010A1 (fr) Nouveaux derives de pyrimido-(2,1-a)isoquinoleine, leur procede de production et composition pharmaceutique les contenant
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
FR2369837A1 (fr) Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant
US3629441A (en) Compositions containing physiologically active kawa compounds process of making same and method of using same in therapy
KR20070114307A (ko) 필수 다중불포화 지방산의 시클릭 글리세리드를 이용한사이토킨 조절인자
FR2390447A1 (fr) Procede de preparation de l'a-2,5,9-trimethylbenzo-(b)-thieno-(2,3-f)-morphane, produit obtenu et composition pharmaceutique le contenant
FR2592043A1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse